Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
9079-5 Protein intake Mass ^Patient Pt Qn Estimated   ACTIVE Protein intake Estimated   MIN DefinitionDescription     g             IO_IN_SALTS+CALS   9079-5   Estimated             0 Protein intake Est           Est; estimation; IO_INTAKE_SALTS+CALORIES; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random 2.48 1.0i               g       0
90790-7 Note Find {Setting} Pt Doc Podiatry.resident   ACTIVE Podiatry Resident Note   ADD DefinitionDescription                   DOC.ONTOLOGY   90790-7   Podiatry.resident     Both       0 Podiatry Res Note           DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Podiatry Res; Point in time; Random; Visit note 2.65 2.65                       0
90791-5 Note Find {Setting} Pt Doc Physical therapy.resident   ACTIVE Physical therapy Resident Note   ADD DefinitionDescription                   DOC.ONTOLOGY   90791-5   Physical therapy.resident     Both       0 PT Res Note           DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; PT; PT Res; Random; Visit note 2.65 2.65                       0
90792-3 Preoperative evaluation and management note Find {Setting} Pt Doc Podiatry.attending   ACTIVE Podiatry Attending Preoperative evaluation and management note   ADD DefinitionDescription                   DOC.ONTOLOGY   90792-3   Podiatry.attending     Both       0 Podiatry Attend Pre-op note           Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Podiatry Attend; Point in time; Pre-Op; Pre-op note; Pre-Operative; Random; Visit note 2.65 2.65                       0
90793-1 Note Find {Setting} Pt Doc Podiatry.attending   ACTIVE Podiatry Attending Note   ADD DefinitionDescription                   DOC.ONTOLOGY   90793-1   Podiatry.attending     Both       0 Podiatry Attend Note           DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Podiatry Attend; Point in time; Random; Visit note 2.65 2.65                       0
90794-9 Vedolizumab & Vedolizumab Ab Panel MCnc Ser/Plas Pt Qn     ACTIVE Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma   ADD DefinitionDescription                   PANEL.DRUG/TOX   90794-9         Order       0 Vedol + Vedol Ab Pnl SerPl-mCnc           DRUG/TOXICOLOGY; Drugs; Entyvio; Level; Mass concentration; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vedol; Vedolizumab + Vedolizumab Ab Pnl; VEMAB 2.65 2.65   Panel                   0
90795-6 Levothyroxine absorption panel - Ser/Plas Pt Qn     ACTIVE Levothyroxine absorption panel - Serum or Plasma   ADD DefinitionDescription                   PANEL.CHAL   90795-6         Order       0 Levothyroxine absorption pnl SerPl           Absorp; c99; CHEMISTRY.CHALLENGE TESTING; Levothyroxine absorption pnl; L-thyroxine; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.65 2.65   Panel                   0
90796-4 Thyroxine^1H post dose levothyroxine MCnc Ser/Plas Pt Qn     ACTIVE Thyroxine (T4) [Mass/volume] in Serum or Plasma --1 hours post dose levothyroxine   ADD DefinitionDescription     mcg/dL             CHAL   90796-4         Observation       0 T4 1h p levo SerPl-mCnc           1 hour; 1.0Hr; 1h p levo; 60 min; 60 minutes; 60M; 60min; After; c99; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4 2.65 2.65               ug/dL       0
90797-2 Thyroxine^2H post dose levothyroxine MCnc Ser/Plas Pt Qn     ACTIVE Thyroxine (T4) [Mass/volume] in Serum or Plasma --2 hours post dose levothyroxine   ADD DefinitionDescription     mcg/dL             CHAL   90797-2         Observation       0 T4 2h p levo SerPl-mCnc           120 min; 120 minutes; 120min; 2 hours; 2h p levo; After; c99; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4 2.65 2.65               ug/dL       0
90798-0 Thyroxine^3H post dose levothyroxine MCnc Ser/Plas Pt Qn     ACTIVE Thyroxine (T4) [Mass/volume] in Serum or Plasma --3 hours post dose levothyroxine   ADD DefinitionDescription     mcg/dL             CHAL   90798-0         Observation       0 T4 3h p levo SerPl-mCnc           3h p levo; After; c99; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4 2.65 2.65               ug/dL       0
90799-8 Thyroxine^4H post dose levothyroxine MCnc Ser/Plas Pt Qn     ACTIVE Thyroxine (T4) [Mass/volume] in Serum or Plasma --4 hours post dose levothyroxine   ADD DefinitionDescription     mcg/dL             CHAL   90799-8         Observation       0 T4 4h p levo SerPl-mCnc           4h p levo; After; c99; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4 2.65 2.65               ug/dL       0
908-4 Ax Ab PrThr Ser/Plas^BPU Pt Ord     ACTIVE Ax Ab [Presence] in Serum or Plasma from Blood product unit   MIN DefinitionDescription                   BLDBK   908-4         Observation       0 Ax Ab SerPl BPU Ql           ABS; Aby; Antby; Anti; Antibodies; Antibody; Ao; Autoantibodies; Autoantibody; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPl^bpu; SerPlas; Serum; Serum or plasma; SR 2.56 1                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
9080-3 Protein intake Mass ^Patient Pt Qn Measured   ACTIVE Protein intake Measured   MIN DefinitionDescription     g             IO_IN_SALTS+CALS   9080-3   Measured             0 Protein intake Measured           IO_INTAKE_SALTS+CALORIES; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random 2.48 1.0i               g       0
90800-4 Thyroxine^6H post dose levothyroxine MCnc Ser/Plas Pt Qn     ACTIVE Thyroxine (T4) [Mass/volume] in Serum or Plasma --6 hours post dose levothyroxine   ADD DefinitionDescription     mcg/dL             CHAL   90800-4         Observation       0 T4 6h p levo SerPl-mCnc           >6h; 6h p levo; After; c99; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4 2.65 2.65               ug/dL       0
90801-2 Thyrotropin^6H post dose levothyroxine ACnc Ser/Plas Pt Qn     ACTIVE Thyrotropin [Units/volume] in Serum or Plasma --6 hours post dose levothyroxine   ADD DefinitionDescription     mIU/mL             CHAL   90801-2         Observation       0 TSH 6h p levo SerPl-aCnc           >6h; 6h p levo; After; Arbitrary concentration; c99; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; L-thyroxine; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH 2.65 2.65               m[IU]/mL       0
90802-0 Medication volume of distribution Vol ^Patient Pt Qn Calculated   ACTIVE Medication volume of distribution Calculated   ADD DefinitionDescription     L     Dose/Concentration at time 0       MEDS   90802-0   Calculated     Observation       0 Med Vd Calc           Calc; Calculation; Med Vd; MEDS; Point in time; QNT; Quan; Quant; Quantitative; Random; Vol; Volume 2.65 2.65               L       0
90803-8 Peak concentration post XXX challenge - baseline concentration increment MCncDiff Ser/Plas Pt Qn Calculated   ACTIVE Post-challenge peak - baseline concentration increment [Mass concentration difference] in Serum or Plasma by calculation   ADD DefinitionDescription     ug/dL     Concentration increment = Peak concentration - baseline concentration       DRUG/TOX   90803-8   Calculated     Observation       0 Conc increment SerPl Calc-MCDiff           After; Calc; Calculation; Conc increment; DRUG/TOXICOLOGY; Drugs; MCDiff; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.65 2.65               ug/dL       0
90804-6 Levothyroxine absorption MFr Ser/Plas Pt Qn Calculated   ACTIVE Levothyroxine absorption in Serum or Plasma by calculation   ADD DefinitionDescription     %     [(Incremental increase in T4 x 10)(Volume of distribution x 100)]/Levothyroxine dose administered       CHAL   90804-6   Calculated     Observation       0 Levothyroxine absorption MFr SerPl Calc           Absorp; c99; Calc; Calculation; CHEMISTRY.CHALLENGE TESTING; L-thyroxine; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.65 2.65               %       0
90805-3 Vedolizumab^trough MCnc Ser/Plas Pt Qn LC/MS/MS   ACTIVE Vedolizumab [Mass/volume] in Serum or Plasma by LC/MS/MS --trough   ADD DefinitionDescription     ug/mL             DRUG/TOX   90805-3   LC/MS/MS     Both       0 Vedolizumab Trough SerPl LC/MS/MS-mCnc           DRUG/TOXICOLOGY; Drugs; Entyvio; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vedol 2.65 2.65               ug/mL       0
90806-1 Candida albicans DNA PrThr Ser Pt Ord Probe.amp.tar   ACTIVE Candida albicans DNA [Presence] in Serum by NAA with probe detection   ADD DefinitionDescription                   MICRO   90806-1   Probe.amp.tar     Both       0 C albicans DNA Ser Ql NAA+probe           3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C albicans; C albicans DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m005; m5; Microbiology; Monilia; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Serum; SR; Strand Displacement Amplification; Thrush; TMA; Transcription mediated amplification 2.65 2.65                       0
90807-9 Candida glabrata DNA PrThr Ser Pt Ord Probe.amp.tar   ACTIVE Candida glabrata DNA [Presence] in Serum by NAA with probe detection   ADD DefinitionDescription                   MICRO   90807-9   Probe.amp.tar     Both       0 C glabrata DNA Ser Ql NAA+probe           3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C glabrata; C glabrata DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Serum; SR; Strand Displacement Amplification; TMA; Torulopsis glabrata; Transcription mediated amplification 2.65 2.65                       0
90808-7 Candida krusei DNA PrThr Ser Pt Ord Probe.amp.tar   ACTIVE Candida krusei DNA [Presence] in Serum by NAA with probe detection   ADD DefinitionDescription                   MICRO   90808-7   Probe.amp.tar     Both       0 C krusei DNA Ser Ql NAA+probe           3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C krusei; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification 2.65 2.65                       0
90809-5 Candida parapsilosis DNA PrThr Ser Pt Ord Probe.amp.tar   ACTIVE Candida parapsilosis DNA [Presence] in Serum by NAA with probe detection   ADD DefinitionDescription                   MICRO   90809-5   Probe.amp.tar     Both       0 C parap DNA Ser Ql NAA+probe           3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C parap; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification 2.65 2.65                       0
9081-1 Protein intake MRat ^Patient 1H Qn     ACTIVE Protein intake 1 hour   MIN DefinitionDescription     g/h             IO_IN_SALTS+CALS   9081-1                 0 Protein intake 1h           1 hour; 1.0Hr; 1HR; 60 min; 60 minutes; 60M; 60min; IO_INTAKE_SALTS+CALORIES; Mass Rate; mRate; PR; Prot; QNT; Quan; Quant; Quantitative 2.48 1.0i               g/h       0
90810-3 Candida tropicalis DNA PrThr Ser Pt Ord Probe.amp.tar   ACTIVE Candida tropicalis DNA [Presence] in Serum by NAA with probe detection   ADD DefinitionDescription                   MICRO   90810-3   Probe.amp.tar     Both       0 C tropicls DNA Ser Ql NAA+probe           3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C tropicls; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification 2.65 2.65                       0
104,672 results found